Brevan Howard Capital Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,530
Closed -$188K 2377
2025
Q4
$188K Buy
+19,530
New +$202K ﹤0.01% 1603
2025
Q2
Sell
-14,183
Closed -$103K 1956
2025
Q1
$103K Buy
+14,183
New +$103K ﹤0.01% 1049
2024
Q4
Sell
-50,813
Closed -$374K 1314
2024
Q3
$374K Buy
+50,813
New +$475K ﹤0.01% 773
2024
Q2
Sell
-24,303
Closed -$336K 1300
2024
Q1
$336K Sell
24,303
-4,389
-15% -$68.5K ﹤0.01% 608
2023
Q4
$557K Buy
+28,692
New +$529K 0.01% 433

Other funds holding NUS

Brevan Howard Capital Management's NUS Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Nu Skin (NUS) in Q1 2026, closing a stake of 19,530 shares — an estimated $188K sold.

Brevan Howard Capital Management first reported a position in NUS in Q4 2023 and held it in 5 quarters. The position peaked at $557K in Q4 2023. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Nu Skin position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 19,530 Nu Skin shares in Q1 2026, an estimated $188K.
  • Brevan Howard Capital Management first reported a position in Nu Skin in Q4 2023 and held it in 5 quarters.
  • Brevan Howard Capital Management's Nu Skin position peaked at $557K in Q4 2023.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.